Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Covetrus, Inc.    CVET

COVETRUS, INC.

(CVET)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

COVETRUS, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

11/10/2020 | 04:17pm EST

Item 2.02 Results of Operations and Financial Condition.

On November 10, 2020, Covetrus, Inc. (the "Company") issued a press release announcing its operating results for the third quarter ended September 30, 2020. A copy of the press release is attached as Exhibit 99.1 to this Report.

The information contained herein and in the accompanying exhibit shall not be incorporated by reference into any filing of the Company, whether made before or after the date hereof. The information in this report, including the exhibit hereto, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or of the Securities Act of 1933, as amended.

Item 9.01 Financial Statements and Exhibits

Exhibit No. Description 99.1 Press Release of Covetrus, Inc. Announcing Third Quarter 2020 Financial Results dated November 10, 2020

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

All news about COVETRUS, INC.
01/13COVETRUS, INC. : Results of Operations and Financial Condition, Regulation FD Di..
AQ
01/06COVETRUS : to Present at the 39th Annual J.P. Morgan Healthcare Conference
BU
01/04COVETRUS : Presidio Announces Appointment of Christine Komola as New CFO
AQ
2020COVETRUS : Completes Separation from Former Parent Company
BU
2020COVETRUS, INC. : Submission of Matters to a Vote of Security Holders, Regulation..
AQ
2020Credit Suisse Adjusts Price Target for Covetrus to $20 From $17, Maintains Ne..
MT
2020COVETRUS : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
2020Covetrus Narrows Q3 Loss Amid Higher Revenue, Ups Full Year Earnings Guidance
MT
2020COVETRUS : 3Q Earnings Snapshot
AQ
2020COVETRUS, INC. : Results of Operations and Financial Condition, Financial Statem..
AQ
More news
Financials (USD)
Sales 2020 4 273 M - -
Net income 2020 -23,0 M - -
Net Debt 2020 674 M - -
P/E ratio 2020 -158x
Yield 2020 -
Capitalization 4 825 M 4 825 M -
EV / Sales 2020 1,29x
EV / Sales 2021 1,20x
Nbr of Employees 5 300
Free-Float 72,5%
Chart COVETRUS, INC.
Duration : Period :
Covetrus, Inc. Technical Analysis Chart | CVET | US22304C1009 | MarketScreener
Technical analysis trends COVETRUS, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 30,00 $
Last Close Price 37,84 $
Spread / Highest target -7,51%
Spread / Average Target -20,7%
Spread / Lowest Target -36,6%
EPS Revisions
Managers and Directors
NameTitle
Benjamin C. Wolin President, Chief Executive Officer & Director
Philip A. Laskaway Chairman
Matthew J. Foulston Chief Financial Officer
Georgina Wraight President-Global Technology Solutions & EVP
Steve Palmucci Global Chief Information Officer
Sector and Competitors
1st jan.Capitalization (M$)
COVETRUS, INC.31.66%4 825
ABBOTT LABORATORIES4.78%196 561
MEDTRONIC PLC-0.20%157 350
BECTON, DICKINSON AND COMPANY4.00%75 691
HOYA CORPORATION-3.92%49 122
ALIGN TECHNOLOGY, INC.0.95%42 537